Dopamine beta-hydroxylase gene polymorphisms and psychotic symptoms in schizophrenia
β Scribed by J.K. Park; J.W. Kim; H.J. Lee; J.H. Chung; E.Y. Ha; D.J. Oh; J.Y. Song
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 46 KB
- Volume
- 144B
- Category
- Article
- ISSN
- 1552-4841
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We studied the relationship between schizophrenia and the DdeI polymorphism in the 5 untranslated region (5UTR) of the dopamine D1 receptor (DRD1) gene. This polymorphism is an A (A1 allele) to G (A2 allele) transition in the 5 UTR of exon 2 at bp -48 (A-48G). One hundred forty-eight schizophrenics
The presence of a polymorphic (GT) n repeat, a microsatellite repeat, at the human dopamine β€-hydroxylase (DBH) gene had been previously investigated in healthy people and in schizophrenic patients. The different DBH genotypes had been found to be associated to different DBH biochemical function, bu
## Abstract Numerous lines of evidence support the role of the catecholamines in the development of tics and Gilles de la Tourette syndrome (GTS). DopamineβΞ²βhydroxylase (DBH) is the key enzyme in the conversion of dopamine to norepinephrine and the alleles of several polymorphisms of the __DBH__ g
To investigate the possible role of the dopamine transporter (DAT) gene in determining the phenotype in human subjects, allele frequencies for the 40-bp variable number of tandem repeats (VNTR) polymorphism at this site were compared between 117 Japanese normal controls and 118 schizophrenic patient